Physician
Gastroenterology
Dr. Dawn C. Torres, MD
|
|
Give Review
Dawn C. Torres is an expert in the field of Gastroenterology. He went to medical school at Uniformed Services University of the Health Sciences. Uniformed Services University of the Health Sciences is ranked 72 in research and 47 in primary care medicine Dawn Torres is also a published physician. He has 22 paper published. The most recent paper is: Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?
Publications
- Nutrition in cirrhosis and chronic liver disease.
- Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?
- Review of treatment options for nonalcoholic Fatty liver disease.
- NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.
- Is it time to write a prescription for coffee? Coffee and liver disease.
- Vitamin D and NAFLD: Is it more than just an association?
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, p...
- Association of coffee and caffeine consumption with fatty liver disease, non-alcoholic steatohepatitis, and degree of hepatic fibrosis.
- Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospec...
- Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series.
- Nonalcoholic fatty liver disease: is it all in the genes?
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.
- Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, op...
- A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.
- Effect of weight loss on nonalcoholic fatty liver disease.
- Current and emerging therapies in nonalcoholic fatty liver disease.
- Hepatitis C virus and insulin resistance/diabetes mellitus.
- HCV replication and statin pleotropism: an adjuvant treatment panacea?
- Insulin resistance in chronic hepatitis C, genotypes 1 and 4: the unfortunate reality.
- Diagnosis and therapy of nonalcoholic steatohepatitis.
- Current treatments in nonalcoholic steatohepatitis.
Schools
State University of New York At Buffalo
New York Hospital
Doctors Specialties
- Pediatrics
- Gastroenterology
Accepted Insurances
Education
-
Johns Hopkins University -
San Antonio Uniformed Services Health Education Consortium -
National Capital Consortium -
Uniformed Services University of the Health Sciences
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan E. Harwin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann J. Maley, MD |
|
|
Dr. Alanna M. Coughlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shari A. Jackson, MD |
|
|
Dr. Laura M. Walby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond C. Seligson, MD
This Doctor is OpenDoctor Recommended.
|